Sonrotoclax (BGB-11417)

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Near Add Your Location

Sorting 22 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Not currently accepting
  • Show Principal Investigator
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients
Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
  • Accepting patients
Memorial Sloan Kettering Bergen
Montvale, NJ
  • Not currently accepting
  • Show Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale, NY
  • Not currently accepting
  • Show Principal Investigator
Weill Cornell
New York, NY
  • Accepting patients
University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Accepting patients
Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 788-8038

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.